MedTrace Logo

Pilot Study to Validate Metallic Markers for Image Guided Radiation Therapy for Breast Cancer Tx

NCT00802932 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 61

Last updated 2013-01-30

No results posted yet for this study

Summary

The purpose of this study is to test metallic markers in the breast tissue after breast conserving surgery and to observe the metallic markers' stability in the breast for use as tumor bed markers and positioning devices for radiation treatment.

Conditions

Interventions

DEVICE

Non-contrast Computed Tomography (CT) Scans (Metallic Markers)

Non-contrast CT Scans prior to start of radiation therapy, and during weeks 2, 4, 6.

DEVICE

Non-contrast CT Scans (Metallic Markers)

Non-contrast CT Scans prior to start of radiation therapy and on Day 5.

Sponsors & Collaborators

  • H. Lee Moffitt Cancer Center and Research Institute

    lead OTHER

Principal Investigators

  • Eleanor Harris, M.D. · H. Lee Moffitt Cancer Center and Research Institute, Inc.

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-03-31
Primary Completion
2012-10-31
Completion
2012-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00802932 on ClinicalTrials.gov